Metabolic & Cardiometabolic
Part of Biotech - Drug Development
 LLY | Eli Lilly & Co. | $1.0t | $1211.50 | +7.4% | 5.3M |
 AZN | AstraZeneca PLC | $287.9b | $188.18 | +1.5% | 2.5M |
 MDGL | Madrigal Pharmaceuticals, Inc. Common Stock | $11.5b | $508.75 | -0.1% | 400.3K |
 PTGX | Protagonist Therapeutics, Inc | $6.4b | $121.83 | -0.6% | 860.4K |
 TERN | Terns Pharmaceuticals, Inc. Common Stock | $6.1b | $52.97 | +0.0% | 2.3M |
 TVTX | Travere Therapeutics, Inc. Common Stock | $4.4b | $60.87 | -0.4% | 1.8M |
 NAMS | NewAmsterdam Pharma Company N.V. Ordinary Shares | $3.9b | $33.20 | +4.7% | 1.4M |
 VKTX | Viking Therapeutics, Inc | $3.8b | $37.87 | +2.8% | 3.0M |
 KNSA | Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares | $3.7b | $59.12 | +4.0% | 1.1M |
 MLYS | Mineralys Therapeutics, Inc. Common Stock | $2.6b | $26.57 | +1.3% | 1.9M |
 MBX | MBX Biosciences, Inc. Common Stock | $1.5b | $53.65 | +3.7% | 1.1M |
 MAZE | Maze Therapeutics, Inc. Common Stock | $1.5b | $29.22 | +5.3% | 1.6M |
 SEPN | Septerna, Inc. Common Stock | $1.4b | $37.24 | +7.7% | 745.1K |
 MNKD | Mannkind Corporation | $1.2b | $4.08 | +5.1% | 5.4M |
 LXRX | Lexicon Pharmaceuticals, Inc. | $1.0b | $2.53 | +10.7% | 7.5M |
 ESPR | Esperion Therapeutics, Inc. | $0.8b | $3.15 | 0.0% | 6.8M |
 BIOA | BioAge Labs, Inc. Common Stock | $0.8b | $23.61 | +4.9% | 1.3M |
 ALT | Altimmune, Inc. Common Stock | $0.6b | $2.83 | -1.4% | 4.0M |
 GYRE | Gyre Therapeutics, Inc. Common Stock | $0.6b | $6.34 | +1.0% | 112.3K |
 SGMT | Sagimet Biosciences Inc. Series A Common Stock | $450.2m | $7.05 | +2.6% | 797.7K |
 RZLT | Rezolute, Inc. Common Stock (NV) | $317.8m | $4.98 | -0.1% | 1.5M |
 TENX | Tenax Therapeutics, Inc. | $314.9m | $13.38 | +4.0% | 1.3M |
 MIST | Milestone Pharmaceuticals Inc. Common Shares | $176.8m | $1.26 | 0.0% | 859.0K |
 ORMP | Oramed Pharmaceuticals Inc. | $162.5m | $4.79 | -6.5% | 564.4K |
 CRDL | Cardiol Therapeutics Inc. Class A Common Shares | $140.6m | $1.07 | +0.5% | 437.9K |
 VTVT | vTv Therapeutics Inc. Class A Common Stock | $131.4m | $34.78 | -7.2% | 89.5K |
 GUTS | Fractyl Health, Inc. Common Stock | $127.9m | $0.77 | -5.0% | 1.2M |
 VANI | Vivani Medical, Inc. Common Stock (DE) | $113.8m | $1.21 | +2.2% | 137.5K |
 BMEA | Biomea Fusion, Inc. Common Stock | $99.8m | $1.29 | +7.3% | 1.2M |
 AARD | Aardvark Therapeutics, Inc. Common Stock | $89.7m | $4.79 | -4.7% | 308.2K |
 VERU | Veru Inc. | $38.0m | $2.92 | +2.2% | 181.7K |
 GRDX | GridAI Technologies Corp. Common Stock | $37.3m | $4.53 | +2.5% | 92.9K |
 ALGS | Aligos Therapeutics, Inc. Common Stock | $35.3m | $5.58 | 0.0% | 35.7K |
 SKYE | Skye Bioscience, Inc. Common Stock | $27.3m | $0.69 | -3.5% | 97.0K |
 NCEL | NewcelX Ltd. Ordinary Shares | $19.0m | $3.77 | -0.8% | 11.7K |
 LPCN | Lipocine Inc. | $18.5m | $2.50 | +4.6% | 18.2K |
 CVKD | Cadrenal Therapeutics, Inc. Common Stock | $15.3m | $3.06 | +5.4% | 44.9K |
 MTVA | MetaVia Inc. Common Stock | $14.7m | $1.45 | -5.9% | 91.7K |
 CURX | Curanex Pharmaceuticals Inc Common Stock | $9.4m | $0.27 | 0.0% | 44.6K |
 ELAB | PMGC Holdings Inc. Common Stock | $8.0m | $1.14 | -0.9% | 300.0K |
 TCRT | Alaunos Therapeutics, Inc. Common Stock | $7.0m | $2.40 | 0.0% | 13.1K |
 GLMD | Galmed Pharmaceuticals Ltd. | $5.0m | $0.54 | -3.5% | 22.3K |